Wang You-Chun, Xu Si-Hong, Li Xiu-Hua, Song Ai-Jing, Jia Xue-Rong, Zhuang Hui
National Institute for the Control of Pharmaceutical and Biological Products, Beijing 100050, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Sep;27(9):777-9.
To study HIV, HBV and HCV infections in intravenous drug users.
2025 blood samples from intravenous drug users were collected from Sichuan, Hunan, Guangxi and Xinjiang regions, and tested for anti-HIV, anti-HCV, HBsAg using enzyme-linked immuno-sobent assays (ELISAs).
The positive rates of anti-HIV,anti-HCV and HBsAg were14.7%-30.4%, 60.7%-85.5% and 6.6%-22.4% in the intravenous drug users, respectively. The co-infection rates of HIV/HBV, HIV/HCV, HCV/HBV and HIV/HCV/HBV were 0%-0.4%, 11.6%-27.2%, 2.3%-14.3% and 1.6%-4.8% respectively in this population.
The infection rates of HIV, HBV and HCV were higher in the intravenous drug users than that in general populations in the same regions, and HIV/HCV co-infection appeared most frequent in this population.
研究静脉吸毒者中的艾滋病毒、乙肝病毒和丙肝病毒感染情况。
从四川、湖南、广西和新疆地区采集2025份静脉吸毒者的血样，采用酶联免疫吸附试验（ELISA）检测抗艾滋病毒、抗丙肝病毒、乙肝表面抗原。
静脉吸毒者中抗艾滋病毒、抗丙肝病毒和乙肝表面抗原的阳性率分别为14.7%-30.4%、60.7%-85.5%和6.6%-22.4%。该人群中艾滋病毒/乙肝病毒、艾滋病毒/丙肝病毒、丙肝病毒/乙肝病毒和艾滋病毒/丙肝病毒/乙肝病毒的合并感染率分别为0%-0.4%、11.6%-27.2%、2.3%-14.3%和1.6%-4.8%。
静脉吸毒者中艾滋病毒、乙肝病毒和丙肝病毒的感染率高于同一地区的普通人群，且该人群中艾滋病毒/丙肝病毒合并感染最为常见。
